IV Fluids Manufacturing
Largest manufacturing footprint to meet critical customer needs1
Meeting Critical Needs
Baxter has invested $1 billion in IV Supply — and counting — over the last five years in manufacturing plants in the U.S. This ongoing investment allows us to expand our manufacturing network to create redundancy, increase production and add capacity — allowing us to meet critical IV supply needs now and in the future.
6 IV manufacturing plants in North America
More than any other competitor
Broadest global network
Enabling redundant supply if needed
The Real Benefit
95% of Baxter IV Fluids are manufactured for the US in North America across six IV plants, building more supply resilience into the US supply chain to better serve our customers.
Responding to Demand
When there are spikes in demand, we are agile enough to adapt and provide our customers with the products they need to care for their patients. In fact, when there were medical fluid shortages, Baxter stepped up to meet this critical need. Throughout the pandemic, and continuing today, we supply IV fluids and irrigation products.
